1. Products
  2. Acitretin Capsules, USP

Acitretin Capsules, USP are indicated for the treatment of severe psoriasis in adults.  Because of significant adverse effects associated with its use, Acitretin Capsules, USP should be prescribed only by those knowledgeable in the systemic use of retinoids.  For more information about acitretin capsules call 1-855-273-0150 or go to www.sigmapharm.com/PPET.

Acitretin Capsules, USP
  • Compare to
    Soriatane®*
Inactive Ingredients

Microcrystalline cellulose, sodium lauryl sulfate, maltodextrin, povidone and sodium ascorbate. The 10-mg, 17.5-mg, and 25-mg gelatin capsule shells contain gelatin, iron oxide (yellow), titanium dioxide, sodium lauryl sulfate and black imprinting ink. In addition, the 17.5-mg gelatin capsule shells also contain iron oxide (red).

*Soriatane® is a registered trademark of Stiefel Laboratories, Inc.

Acitretin Capsules, USP (10 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    10 mg
  • NDC Code
    42794-0080-08
Acitretin Capsules, USP (10 mg)

Acitretin Capsules, USP (17.5 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    17.5 mg
  • NDC Code
    42794-0081-08
Acitretin Capsules, USP (17.5 mg)

Acitretin Capsules, USP (25 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    25 mg
  • NDC Code
    42794-0083-08
Acitretin Capsules, USP (25 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.